Literature DB >> 20660744

Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development.

Michelle J Boyle1, Danny W Wilson, Jack S Richards, David T Riglar, Kevin K A Tetteh, David J Conway, Stuart A Ralph, Jake Baum, James G Beeson.   

Abstract

During blood-stage infection by Plasmodium falciparum, merozoites invade RBCs. Currently there is limited knowledge of cellular and molecular invasion events, and no established assays are available to readily measure and quantify invasion-inhibitory antibodies or compounds for vaccine and drug studies. We report the isolation of viable merozoites that retain their invasive capacity, at high purity and yield, purified by filtration of highly synchronous populations of schizonts. We show that the half-life of merozoite invasive capacity after rupture is 5 min at 37 degrees C, and 15 min at room temperature. Studying the kinetics of invasion revealed that 80% of invasion events occur within 10 min of mixing merozoites and RBCs. Invasion efficiency was maximum at low merozoite-to-RBC ratios and occurred efficiently in the absence of serum and with high concentrations of dialyzed nonimmune serum. We developed and optimized an invasion assay by using purified merozoites that enabled invasion-inhibitory activity of antibodies and compounds to be measured separately from other mechanisms of growth inhibition; the assay was more sensitive for detecting inhibitory activity than established growth-inhibition assays. Furthermore, with the use of purified merozoites it was possible to capture and fix merozoites at different stages of invasion for visualization by immunofluorescence microscopy and EM. We thereby demonstrate that processing of the major merozoite antigen merozoite surface protein-1 occurs at the time of RBC invasion. These findings have important implications for defining invasion events and molecular interactions, understanding immune interactions, and identifying and evaluating inhibitors to advance vaccine and drug development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660744      PMCID: PMC2922570          DOI: 10.1073/pnas.1009198107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1.

Authors:  Karen S Harris; Joanne L Casey; Andrew M Coley; Rosella Masciantonio; Jennifer K Sabo; David W Keizer; Erinna F Lee; Andrew McMahon; Raymond S Norton; Robin F Anders; Michael Foley
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody.

Authors:  A M Coley; K Parisi; R Masciantonio; J Hoeck; J L Casey; V J Murphy; K S Harris; A H Batchelor; R F Anders; M Foley
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Authors:  Faith H A Osier; Gregory Fegan; Spencer D Polley; Linda Murungi; Federica Verra; Kevin K A Tetteh; Brett Lowe; Tabitha Mwangi; Peter C Bull; Alan W Thomas; David R Cavanagh; Jana S McBride; David E Lanar; Margaret J Mackinnon; David J Conway; Kevin Marsh
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

4.  Estimating the burden of global mortality in children aged <5 years by pathogen-specific causes.

Authors:  Salenna R Elliott; James G Beeson
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

5.  Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites.

Authors:  Michelle J Boyle; Jack S Richards; Paul R Gilson; Wengang Chai; James G Beeson
Journal:  Blood       Date:  2010-03-10       Impact factor: 22.113

6.  Studies on glycoproteins in the human malaria parasite Plasmodium falciparum. Identification of a myristilated 45kDa merozoite membrane glycoprotein.

Authors:  R Ramasamy
Journal:  Immunol Cell Biol       Date:  1987-10       Impact factor: 5.126

7.  Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites.

Authors:  Paul R Gilson; Brendan S Crabb
Journal:  Int J Parasitol       Date:  2008-10-11       Impact factor: 3.981

8.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

9.  Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites.

Authors:  Sheetij Dutta; J David Haynes; J Kathleen Moch; Arnoldo Barbosa; David E Lanar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-02       Impact factor: 11.205

10.  Molecular identification of a malaria merozoite surface sheddase.

Authors:  Philippa K Harris; Sharon Yeoh; Anton R Dluzewski; Rebecca A O'Donnell; Chrislaine Withers-Martinez; Fiona Hackett; Lawrence H Bannister; Graham H Mitchell; Michael J Blackman
Journal:  PLoS Pathog       Date:  2005-11-25       Impact factor: 6.823

View more
  140 in total

1.  Profiling the Essential Nature of Lipid Metabolism in Asexual Blood and Gametocyte Stages of Plasmodium falciparum.

Authors:  Sonia Gulati; Eric H Ekland; Kelly V Ruggles; Robin B Chan; Bamini Jayabalasingham; Bowen Zhou; Pierre-Yves Mantel; Marcus C S Lee; Natasha Spottiswoode; Olivia Coburn-Flynn; Daisy Hjelmqvist; Tilla S Worgall; Matthias Marti; Gilbert Di Paolo; David A Fidock
Journal:  Cell Host Microbe       Date:  2015-09-09       Impact factor: 21.023

2.  Inside scoop on outside proteins.

Authors:  Jeffrey D Dvorin
Journal:  Infect Immun       Date:  2013-12-16       Impact factor: 3.441

3.  Predicting optimal transmission investment in malaria parasites.

Authors:  Megan A Greischar; Nicole Mideo; Andrew F Read; Ottar N Bjørnstad
Journal:  Evolution       Date:  2016-06-24       Impact factor: 3.694

4.  Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion.

Authors:  Prakash Srinivasan; Wandy L Beatty; Ababacar Diouf; Raul Herrera; Xavier Ambroggio; J Kathleen Moch; Jessica S Tyler; David L Narum; Susan K Pierce; John C Boothroyd; J David Haynes; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

5.  Whole-Cell Phenotypic Screening of Medicines for Malaria Venture Pathogen Box Identifies Specific Inhibitors of Plasmodium falciparum Late-Stage Development and Egress.

Authors:  Alok Tanala Patra; Tejashri Hingamire; Meenakshi A Belekar; Aoli Xiong; Gowtham Subramanian; Zbynek Bozdech; Peter Preiser; Dhanasekaran Shanmugam; Rajesh Chandramohanadas
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

6.  Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial.

Authors:  Antje Blank; Kristin Fürle; Anja Jäschke; Michael Lanzer; Walter E Haefeli; Hermann Bujard; Gerd Mikus; Monika Lehmann; Johannes Hüsing; Kirsten Heiss; Thomas Giese; Darrick Carter; Ernst Böhnlein
Journal:  NPJ Vaccines       Date:  2020-01-31       Impact factor: 7.344

Review 7.  Advances in molecular genetic systems in malaria.

Authors:  Tania F de Koning-Ward; Paul R Gilson; Brendan S Crabb
Journal:  Nat Rev Microbiol       Date:  2015-06       Impact factor: 60.633

Review 8.  The roles of intramembrane proteases in protozoan parasites.

Authors:  L David Sibley
Journal:  Biochim Biophys Acta       Date:  2013-12

9.  Sequential processing of merozoite surface proteins during and after erythrocyte invasion by Plasmodium falciparum.

Authors:  Michelle J Boyle; Christine Langer; Jo-Anne Chan; Anthony N Hodder; Ross L Coppel; Robin F Anders; James G Beeson
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

10.  Synchrony in malaria infections: how intensifying within-host competition can be adaptive.

Authors:  Megan A Greischar; Andrew F Read; Ottar N Bjørnstad
Journal:  Am Nat       Date:  2013-12-16       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.